Advanced Cell Technology, Inc. Stock OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

10/02/16	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
22/01/16	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
28/12/15	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
03/12/15	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
25/11/15	Ocata Therapeutics : Harwood Feffer LLP : Announces Investigation of Ocata Therapeutics, Inc.	PR

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	03/02/2015

Director	Title	Age	Since
Percival Barretto-Ko BRD	Director/Board Member	53	-
Masaaki Hirano BRD	Director/Board Member	59	-
Toru Yoshimitsu BRD	Director/Board Member	63	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+1.84%	-0.66%	+59.82%	+94.48%	54.88B
ARGENX SE	-0.63%	-6.84%	+55.40%	+127.65%	54.63B
INSMED INCORPORATED	-4.68%	-1.31%	+8.04%	+424.94%	25.06B
BIONTECH SE	-0.11%	-2.68%	-17.65%	-16.53%	23.14B
WUXI BIOLOGICS (CAYMAN) INC.	-1.69%	-1.27%	+39.51%	-8.30%	19.87B
GENMAB A/S	+1.11%	+3.67%	+38.08%	-26.77%	17.55B
PHARMAESSENTIA CORPORATION	-6.84%	+2.18%	+195.12%	+364.56%	16.5B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-2.42%	-3.72%	+47.02%	+635.77%	15.75B
EXELIXIS, INC.	-1.93%	-0.56%	+21.15%	+185.37%	14.2B
Average	-1.76%	-0.28%	+49.61%	+197.91%	26.84B
Weighted average by Cap.	-1.10%	-1.45%	+48.92%	+167.45%

Employees

Sector